John Kennedy, the former CEO of the NJMEP, writes about the future of manufacturing and the need for "a feasible plan" to ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each ...